Skip to content

Insider · CIK 0001179552

George M Milne Jr

director

Files at AMLX (Amylyx Pharmaceuticals, Inc.). First filing Oct 7, 2026, latest Oct 7, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $831k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AMLX: Amylyx Pharmaceuticals, Inc.

AMLXOct 9, 2026 · close 28.14

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
18Weak
AMLXsell10b5-1
Amylyx Pharmaceuticals, Inc.
$831k
30,000 shares
-4%+144% from low-30% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 5, 2026AMLX
Amylyx Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-30,000$27.70$831k782,8815 d ago
Jun 5, 2025AMLX
Amylyx Pharmaceuticals, Inc.
AGrant or award
Stock Option (right to buy)derivative
+25,000$0.00$025,000Jun 9, 2025
Jan 24, 2025AMLX
Amylyx Pharmaceuticals, Inc.
GGift
Common Stock
-27,910$0.00$0830,661Jan 28, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

George M Milne Jr: insider trades and track record | InsiderTell